Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year follow-up of more than 13,000 patients from the ETNA-AF-Europe study

Back

ESC Professional Premium Access

Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year follow-up of more than 13,000 patients from the ETNA-AF-Europe study

Session: Atrial fibrillation stroke prevention with oral anticoagulants in difficult cases

Topic: Oral Anticoagulation

Speaker: Professor R. De Caterina (Pisa, IT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Raffaele De Caterina

University of Pisa, Pisa (Italy)

37 presentations

2 followers

7 more presentations in this session

Anticoagulation-associated bleeding in patients randomised to screening for atrial fibrillation or usual care

Speaker: Doctor E. Kongebro (Copenhagen, DK)

Safety and efficacy of anticoagulation for atrial fibrillation in cirrhotic patients

Speaker: Doctor J. Song (Los Angeles, US)

Anticoagulation therapy in patients with atrial fibrillation and active cancer

Speaker: Doctor J. Jaakkola (Turku, FI)

Individual risk prediction of anticoagulation in atrial fibrillation patients with cirrhosis

Speaker: Assistant Professor I. Kim (Seoul, KR)

Impact of oral anticoagulants in frail atrial fibrillation patients: a report from an observational registry of european patients

Speaker: Associate Professor M. Proietti (Milan, IT)

Access the full session

Atrial fibrillation stroke prevention with oral anticoagulants in difficult cases

Speakers: Professor R. De Caterina, Doctor E. Kongebro, Doctor J. Song, Doctor J. Jaakkola, Assistant Professor I. Kim...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources